Friday August 7, 2026
Section

Health

FDA Approves First mRNA Flu Vaccine for Individuals 50 and Older

FDA Approves First mRNA Flu Vaccine for Individuals 50 and Older

The U.S. Food and Drug Administration (FDA) has approved Moderna's mFlusiva, the first mRNA-based vaccine for influenza, for individuals aged 50 and older. This new vaccine has shown higher effectiveness in clinical trials compared to traditional…

Read Full Story